International Biomedical Devices Inc.
Capsulotomy system simplifies and improves cataract surgery
This article was originally published in Start Up
An automated method to ensure a precise incision of the capsular bag for cataract surgery should soon be commercially available from International Biomedical Devices Inc. The Aperture Continuous Thermal Capsulotomy System (ApertureCTC) uses thermal energy delivered through a microincision to a 360-degree, small, steel ring placed on the anterior capsule to create a perfectly round and smooth incision in mere milliseconds.
You may also be interested in...
Perrigo says 2024 results will be slowed by investment in companywide investment and efficiency project including staff reductions. After Opill’s expected launch by late March, sales will be dilutive to earnings for the first year partly due to investments in the brand, primarily at retailers and online in Q2.
Janux reported early clinical trial data for its lead asset JANX007 that may show differentiated efficacy in the crowded PSMA space and for an EGFR agent with lung and kidney tumor shrinkage.
Incyte’s Jakafi-dominated portfolio gained Opzelura as a second source of significant revenue in 2021. While further diversification has been limited, new and existing R&D assets may deliver upside in 2024.